Drug Shortage Report for VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
| Report ID | 261396 |
| Drug Identification Number | 02139375 |
| Brand name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
| Common or Proper name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | VANCOMYCIN |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500mg |
| ATC code | J01XA |
| ATC description | OTHER ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-06-30 |
| Estimated end date | 2025-10-30 |
| Actual end date | 2025-10-30 |
| Shortage status | Resolved |
| Updated date | 2025-10-31 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Vancomycin Hydrochloride for Injection, USP 500 mg Vial effective June 30, 2025, until October 17, 2025. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2025-10-31 | English | Compare |
| v9 | 2025-10-30 | French | Compare |
| v8 | 2025-10-30 | English | Compare |
| v7 | 2025-10-17 | French | Compare |
| v6 | 2025-10-17 | English | Compare |
| v5 | 2025-09-25 | French | Compare |
| v4 | 2025-09-25 | English | Compare |
| v3 | 2025-07-01 | English | Compare |
| v2 | 2025-06-30 | French | Compare |
| v1 | 2025-06-30 | English | Compare |
Showing 1 to 10 of 10